Showing results (521-530 of 863) with videos related to
Sort By:
Pageof 87
Med (New York, N.Y.)|March 15, 2025
A new standard for HCC: The high stakes of TACE-immunotherapy combinationsAntonio D'Alessio, Lorenza RimassaMed (New York, N.Y.)|March 15, 2025
Guselkumab in moderately to severely active ulcerative colitis: Another interleukin-23p19 subunit inhibitor or more?Ambrogio Orlando, Fabio Salvatore MacalusoMed (New York, N.Y.)|October 24, 2024
Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive diseaseDimitrios C Ladakis, Kimystian L Harrison, Matthew D Smith, et al.Med (New York, N.Y.)|October 17, 2024
Correlation of PSA and survival in metastatic hormone-sensitive prostate cancer treated with rezvilutamide plus ADT in the CHART trialXiaojie Bian, Weijie Gu, Xuepei Zhang, et al.Med (New York, N.Y.)|October 12, 2024
Treatment of chronic hand eczema with topical anti-inflammatory drugs other than topical corticosteroidsHidehisa Saeki, Naoko KandaMed (New York, N.Y.)|October 12, 2024
Trofinetide treatment for Rett syndrome: Lessons to learnDaniela TropeaMed (New York, N.Y.)|October 10, 2024
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trialQing Zhou, Yan Yu, Ligang Xing, et al.Med (New York, N.Y.)|October 12, 2024
Twice-yearly lenacapavir: A milestone for HIV prevention in young African womenSilvia Nozza, Antonella CastagnaMed (New York, N.Y.)|August 8, 2024
Multisystem health comorbidity networks of metabolic dysfunction-associated steatotic liver diseaseFangyuan Jiang, Lijuan Wang, Haochao Ying, et al.Med (New York, N.Y.)|August 1, 2024
Tumor microenvironment RNA test to predict immunotherapy outcomes in advanced gastric cancer: The TIMES001 trialMin Shi, Dongqiang Zeng, Huiyan Luo, et al.Pageof 87